BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14662994)

  • 1. Trichosporon inkin peritonitis treated with caspofungin.
    Madariaga MG; Tenorio A; Proia L
    J Clin Microbiol; 2003 Dec; 41(12):5827-9. PubMed ID: 14662994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B.
    Bassetti M; Bisio F; Di Biagio A; Pierri I; Balocco M; Soro O; Cruciani M; Bassetti D
    J Antimicrob Chemother; 2004 Aug; 54(2):575-7. PubMed ID: 15231763
    [No Abstract]   [Full Text] [Related]  

  • 3. Trichosporon inkin peritonitis during continuous ambulatory peritoneal dialysis with bibliography review.
    Lopes JO; Alves SH; Klock C; Oliveira LT; Dal Forno NR
    Mycopathologia; 1997; 139(1):15-8. PubMed ID: 9511232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichosporon asahii following polymicrobial infection in peritoneal dialysis-associated peritonitis.
    Jian DY; Yang WC; Chen TW; Lin CC
    Perit Dial Int; 2008; 28(1):100-1. PubMed ID: 18178957
    [No Abstract]   [Full Text] [Related]  

  • 5. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
    Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
    Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
    Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
    Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal post-operative Trichoderma longibrachiatum mediastinitis and peritonitis in a paediatric patient with complex congenital cardiac disease on peritoneal dialysis.
    Santillan Salas CF; Joshi AY; Dhiman N; Banerjee R; Huskins WC; Wengenack NL; Henry NK
    J Med Microbiol; 2011 Dec; 60(Pt 12):1869-1871. PubMed ID: 21799200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichosporon asahii infection of a dialysis PTFE arteriovenous graft.
    Krzossok S; Birck R; Henke S; Hof H; van der Woude FJ; Braun C
    Clin Nephrol; 2004 Jul; 62(1):66-8. PubMed ID: 15267017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy.
    O'Gorman C; McMullan R; Webb CH; Bedi A
    Ulster Med J; 2006 Sep; 75(3):226-7. PubMed ID: 16964817
    [No Abstract]   [Full Text] [Related]  

  • 10. Caspofungin: the first of a new class of antifungal agents.
    Valgus JM
    Cancer Pract; 2001; 9(6):314-6. PubMed ID: 11879335
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful outpatient treatment of Trichosporon beigelii peritonitis with oral fluconazole.
    Melez KA; Cherry J; Sanchez C; Ettinger RB; Walsh TJ
    Pediatr Infect Dis J; 1995 Dec; 14(12):1110-3. PubMed ID: 8745028
    [No Abstract]   [Full Text] [Related]  

  • 12. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
    Walsh TJ; Teppler H; Donowitz GR; Maertens JA; Baden LR; Dmoszynska A; Cornely OA; Bourque MR; Lupinacci RJ; Sable CA; dePauw BE
    N Engl J Med; 2004 Sep; 351(14):1391-402. PubMed ID: 15459300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
    Steinbach WJ; Schell WA; Miller JL; Perfect JR; Martin PL
    J Infect; 2004 Jan; 48(1):112-6. PubMed ID: 14667801
    [No Abstract]   [Full Text] [Related]  

  • 14. Caspofungin versus liposomal amphotericin B for empirical therapy.
    Jones BL; McLintock LA
    N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675090
    [No Abstract]   [Full Text] [Related]  

  • 15. Caspofungin in the treatment of invasive fungal infections.
    Keady S; Thacker M
    Intensive Crit Care Nurs; 2006 Feb; 22(1):59-62. PubMed ID: 16006127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia.
    Asada N; Uryu H; Koseki M; Takeuchi M; Komatsu M; Matsue K
    Clin Infect Dis; 2006 Aug; 43(4):e39-41. PubMed ID: 16838224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New options for the treatment of invasive fungal infections.
    Rubin ZA; Somani J
    Semin Oncol; 2004 Apr; 31(2 Suppl 4):91-8. PubMed ID: 15124141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of peritoneal dialysis related fungal peritonitis with caspofungin plus amphotericin B combination therapy.
    Fourtounas C; Marangos M; Kalliakmani P; Savidaki E; Goumenos DS; Vlachojannis JG
    Nephrol Dial Transplant; 2006 Jan; 21(1):236-7. PubMed ID: 16263742
    [No Abstract]   [Full Text] [Related]  

  • 19. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin.
    Matsue K; Uryu H; Koseki M; Asada N; Takeuchi M
    Clin Infect Dis; 2006 Mar; 42(6):753-7. PubMed ID: 16477548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin.
    Cooke FJ; Terpos E; Boyle J; Rahemtulla A; Rogers TR
    Clin Microbiol Infect; 2003 Dec; 9(12):1238-41. PubMed ID: 14686991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.